Elsevier

Gene

Volume 363, 19 December 2005, Pages 15-23
Gene

Review
Acetylation and deacetylation of non-histone proteins

https://doi.org/10.1016/j.gene.2005.09.010Get rights and content

Abstract

Since the first report of p53 as a non-histone target of a histone acetyltransferase (HAT), there has been a rapid proliferation in the description of new non-histone targets of HATs. Of these, transcription factors comprise the largest class of new targets. The substrates for HATs extend to cytoskeletal proteins, molecular chaperones and nuclear import factors. Deacetylation of these non-histone proteins by histone deacetylases (HDACs) opens yet another exciting new field of discovery in the role of the dynamic acetylation and deacetylation on cellular function. This review will focus on these non-histone targets of HATs and HDACs and the consequences of their modification.

Introduction

Protein acetylation is a widespread phenomenon among eukaryotes. Co-translational Nα-terminal acetylation is one of the most frequent protein modifications, occurring on approximately 85% of eukaryotic proteins (Polevoda and Sherman, 2000). A less common, but perhaps more important, form of protein acetylation takes place post-translationally on the ɛ-amino group of lysines. The addition of an acetyl group on lysines prevents positive charges from forming on the amino group, and as a result, has a significant impact on the electrostatic properties of the protein. Early studies suggested that many lysine residues in histones are acetylated abundantly and that acetylation of histones regulates gene transcription (Allfrey et al., 1964, Allfrey, 1996, Vidali et al., 1968). An enzyme responsible for histone acetylation, HAT A, was identified initially in Tetrahymena (Brownell et al., 1996). HAT A possesses a high degree of amino acid sequence similarity to the yeast protein GCN5, which also catalyzes histone acetylation. Subsequently, about 30 proteins have been found to contain histone acetyltransferase activity. Each of these HATs may have a particular histone substrate specificity, and different HATs are specific with regard to which histone amino acids they will acetylate. Interestingly, many “histone” acetyltransferases have a wide range of protein substrates in addition to histones.

Unlike Nα-terminal acetylation, post-translational ε-amino lysine acetylation of proteins is highly reversible. In humans, there are 18 potential deacetylase enzymes, HDAC1 to HDAC11 and SIRT1 to SIRT7, which are responsible for the removal of acetyl groups and maintenance of the equilibrium of lysine acetylation in histones. Like HATs, histone deacetylases (HDACs) also possess substrate specificity and accumulating evidence suggests that many, if not all, HDACs can deacetylate non-histone proteins at least in vitro. While many recent reviews discuss non-histone acetylation, we will focus primarily on the functional consequences of acetylation and importantly, deacetylation, of non-histone proteins.

Section snippets

p53

The founding member of non-histone targets of HAT acetylation is the tumor suppressor and sequence-specific DNA-binding transcription factor p53 (Gu and Roeder, 1997). p53 is acetylated by p300/CBP at multiple lysine residues at the C-terminal DNA binding regulatory domain. Acetylation of p53 by p300/CBP activates its sequence-specific DNA binding activity and, consequently, increases activation of its target genes. Although a report suggested that acetylation of the C terminus of p53 by p300

α-Tubulin

In addition to transcription factors, other classes of non-histone proteins are regulated by dynamic acetylation and deacetylation. The best characterized is the cytoskeletal protein α-tubulin. Although acetylation of α-tubulin was found in mammalian cells almost two decades ago, the acetyltransferase responsible remains unidentified (L'Hernault and Rosenbaum, 1985, Maruta et al., 1986, Schulze et al., 1987). Stable microtubules contain high levels of acetylated α-tubulin. In contrast, dynamic

E1A

Besides the many cellular proteins described above, some virally encoded proteins also are substrates of acetylation and deacetylation. Because the adenovirus E1A protein binds p300/CBP, it was not surprising to find that the E1A protein can be acetylated by p300 and PCAF. A study by Zhang et al. (2000) showed that one of the acetylation sites on 12S E1A is located at lysine 239, a residue that is adjacent to the C-terminal binding protein (CtBP) binding motif. Mutation of lysine 239 inhibited

Conclusions and future directions

It has been proposed that acetylation is a regulatory modification that rivals phosphorylation (Kouzarides, 2000). Although the exact number and variety of proteins that are post-translationally lysine-acetylated in the cell is still unknown, it is clear that far more proteins are modified by this mechanism than initially appreciated. Dynamic acetylation of non-histone proteins has pleiotropic effects on cellular function (Table 1). Given this wide array of possible outcomes, it is not possible

Acknowledgments

We apologize to all investigators whose works were not cited in this article due to space limitation. Work in our laboratory is supported by grants from the National Institutes of Health and an endowment from the Kaul Foundation.

References (93)

  • L. Gaughan et al.

    Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor

    J. Biol. Chem.

    (2002)
  • E. Gronroos et al.

    Control of Smad7 stability by competition between acetylation and ubiquitination

    Mol. Cell

    (2002)
  • W. Gu et al.

    Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

    Cell

    (1997)
  • A. Ianari et al.

    Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA damage

    J. Biol. Chem.

    (2004)
  • J.W. Jeong

    Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation

    Cell

    (2002)
  • L.J. Juan

    Histone deacetylases specifically down-regulate p53-dependent gene activation

    J. Biol. Chem.

    (2000)
  • R. Kiernan

    Post-activation turn-off of NF-kappaB-dependent transcription is regulated by acetylation of p65

    J. Biol. Chem.

    (2003)
  • J.J. Kovacs

    HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor

    Mol. Cell

    (2005)
  • J. Luo

    Negative control of p53 by Sir2alpha promotes cell survival under stress

    Cell

    (2001)
  • D.L. Madison et al.

    Acetylation of the adenovirus-transforming protein E1A determines nuclear localization by disrupting association with importin-alpha

    J. Biol. Chem.

    (2002)
  • G. Marzio et al.

    E2F family members are differentially regulated by reversible acetylation

    J. Biol. Chem.

    (2000)
  • J.J. Mu

    The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis

    Virology

    (2004)
  • N. Munshi et al.

    Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome

    Mol. Cell

    (1998)
  • B.J. North et al.

    The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

    Mol. Cell

    (2003)
  • Y. Ozawa

    Histone deacetylase 3 associates with and represses the transcription factor GATA-2

    Blood

    (2001)
  • A. Polesskaya et al.

    Acetylation of MyoD by p300 requires more than its histone acetyltransferase domain

    J. Biol. Chem.

    (2001)
  • A. Polesskaya

    CREB-binding Protein/p300 activates MyoD by acetylation

    J. Biol. Chem.

    (2000)
  • B. Polevoda et al.

    N-alpha -terminal acetylation of eukaryotic proteins

    J. Biol. Chem.

    (2000)
  • V. Sartorelli

    Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program

    Mol. Cell

    (1999)
  • J.M. Serrador et al.

    HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization

    Immunity

    (2004)
  • Y. Shi et al.

    Everything you have ever wanted to know about Yin Yang 1

    Biochim. Biophys. Acta

    (1997)
  • M. Simonsson et al.

    The balance between acetylation and deacetylation controls Smad7 stability

    J. Biol. Chem.

    (2005)
  • R. Sterner et al.

    Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1

    J. Biol. Chem.

    (1979)
  • M.J. Thomas et al.

    Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?

    Gene

    (1999)
  • J.O. Thomas et al.

    HMG1 and 2, and related ‘architectural’ DNA-binding proteins

    Trends Biochem. Sci.

    (2001)
  • H. Vaziri

    hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

    Cell

    (2001)
  • G. Vidali et al.

    Chemical studies of histone acetylation. The distribution of epsilon-N-acetyllysine in calf thymus histones

    J. Biol. Chem.

    (1968)
  • C. Wang

    Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity

    J. Biol. Chem.

    (2001)
  • W. Wang

    AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: involvement in the nuclear import of RNA-binding protein HuR

    J. Biol. Chem.

    (2004)
  • R. Wang et al.

    Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation

    J. Biol. Chem.

    (2005)
  • W.M. Yang et al.

    Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family

    J. Biol. Chem.

    (1997)
  • V.G. Allfrey

    Structural modifications of histones and their possible role in the regulation of ribonucleic acid synthesis

    Proc. Can. Cancer Res. Conf.

    (1996)
  • V.G. Allfrey et al.

    Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis

    Proc. Natl. Acad. Sci. U. S. A.

    (1964)
  • F. Bernassola

    Ubiquitin-dependent degradation of p73 is inhibited by PML

    J. Exp. Med.

    (2004)
  • J. Boyes et al.

    Regulation of activity of the transcription factor GATA-1 by acetylation

    Nature

    (1998)
  • M. Bustin

    Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins

    Mol. Cell. Biol.

    (1999)
  • Cited by (0)

    View full text